Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • EBA Publishes Final Regulatory Products To Harmonise The Supervisory Review And Evaluation Process Of Investment Firms

    Date 21/07/2022

    The European Banking Authority (EBA) jointly with the European Securities and Markets Authority (ESMA), published today the final Guidelines on common procedures and methodologies for the supervisory review and evaluation process (SREP) for investment firms. The EBA published also the final draft Regulatory Technical Standards (RTS) on Pillar 2 add-ons for investment firms. Both regulatory products are based on the Investment Firms Directive (IFD) and aim to harmonise the supervisory practices regarding the supervisory review and evaluation process of investment firms.

  • ESMA Finds NCAs' Scrutiny And Approval Of Prospectuses Satisfactory

    Date 21/07/2022

    The European Securities and Markets Authority (ESMA), the EU’s securities markets regulator, is today publishing its Peer Review Report  on the scrutiny and approval procedures of prospectuses by competent authorities. This peer review also assessed the impact of different approaches regarding scrutiny and approval by competent authorities on issuers’ ability to raise capital in the European Union.

  • The EBA Observes A Reduction Of High Earners In 2020 And A Slight Decrease Of Bonus Levels In The Context Of The COVID-19 Pandemic

    Date 21/07/2022

    The European Banking Authority (EBA) published today its Report on benchmarking of remuneration practices in EU banks for the financial years 2019 and 2020 and high earners data (EU27/EEA) for 2020. The number of high earners went down from 1 444 (EU27/EEA) or 4 963 (EU28/EEA) in 2019 to 1 383 (EU27/EEA) in 2020. While the bonus level for high earners remained relatively stable, a visible reduction can be observed for risk takers (identified staff).

  • Virax Biolabs Completes IPO - Shares Begin Trading Today On NASDAQ Capital Market As VRAX

    Date 21/07/2022

    Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today announced it has completed its initial public offering (IPO), and the Company’s shares began trading today on the Nasdaq Capital Market under the ticker symbol "VRAX."
     

  • SEC Charges Former Coinbase Manager, Two Others In Crypto Asset Insider Trading Action

    Date 21/07/2022

    The Securities and Exchange Commission today announced insider trading charges against a former Coinbase product manager, his brother, and his friend for perpetrating a scheme to trade ahead of multiple announcements regarding certain crypto assets that would be made available for trading on the Coinbase platform.